EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudieOpen Access · CC BY 4.0

Pelvic Organ Prolapse Repair Using Robotic-Assisted Sacral Hysterocolpopexy vs Vaginal Surgery with the Uphold™ System: 1-Year Clinical Outcomes

Georgios Poutakidis, Christian Falconer, Daniel Altman, Ulrika Johannesson, Anju Zhang, Charlotta Ericson, Mats Stenberg, Sabine Altrock, Edward Morcos

International Urogynecology Journal · 2025

DOI: 10.1007/s00192-024-06017-6 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Urogynecology Journal, 2025. Verfasst von Georgios Poutakidis und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Division of Obstetrics and Gynecology, Karolinska Institutet Danderyd Hospital, SE- 182 88, Stockholm, Sweden. Hauptthemen laut MEDLINE: Pelvic Organ Prolapse, Robotic Surgical Procedures, Vagina, Gynecologic Surgical Procedures. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Karolinska Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction and Hypothesis The aim of the study was to compare clinical outcomes when using robotic-assisted sacral hysterocolpopexy (RASC) and vaginal surgery using the Uphold™ Vaginal Support System mesh for pelvic organ prolapse repair.

Methods

This was a nonrandomized, prospective, multicenter study in which 72 women underwent RASC, and 73 Uphold™ surgery, for apical prolapse (POP-Q C ≥ stage II). Anatomical outcomes were assessed using the Pelvic Organ Prolapse Quantification (POP–Q) system. Subjective outcomes were evaluated using the Pelvic Floor Distress Inventory 20 (PFDI-20), the Pelvic Floor Impact Questionnaire – short form (PFIQ-7), and the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12), as well as pain estimation using the visual analog scale (0–10).

Results

One year after surgery, an optimal apical segment outcome (POP-Q C stage 0–1) was achieved in 96.4% and 93.3% for the RASC and Uphold™ respectively, p = 0.49. However, reoperation for prolapse recurrence was significantly more common after RASC (11 out of 72 [15.3%] vs Uphold™ (2 out of 71 [2.8%], p = 0.005), and an optimal outcome of the anterior vaginal wall was higher after Uphold™ ( p < 0.001). Postoperative PFDI-20, PFIQ-7, and pain significantly improved for both RASC and Uphold™ ( p = 0.004 to < 0.001), but a more pronounced improvement in the total PFDI-20 and POPDI-6 sub-scores was observed after Uphold™ than after RASC (−73 ± 55.6 vs −49.2 ± 43.7, p = 0.005 and −39.6 ± 23.6 vs −27 ± 23.9, p < 0.001 respectively).

Conclusions

Reoperation for prolapse recurrence within 1 year was more common after RASC than after Uphold™. However, the rate of complications was low overall and there were few and largely insignificant differences in outcomes when comparing RASC and Uphold™.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pelvic Organ ProlapseRobotic Surgical ProceduresVaginaGynecologic Surgical ProceduresHumansFemaleProspective StudiesMiddle AgedAgedTreatment OutcomeSurgical MeshSacrumRecurrenceReoperationSurveys and Questionnaires

Stichwörter der Autor:innen

Anatomical and patient-reported prolapse outcomesApical prolapse surgeryEffectivenessRobotic-assisted sacral hysterocolpopexySafetyUphold™ vaginal mesh

Autor:innen und Institutionen

  • Department of Clinical Sciences, Division of Obstetrics and Gynecology, Karolinska Institutet Danderyd Hospital, SE- 182 88, Stockholm, Sweden.
  • Department of Obstetrics and Gynecology, Danderyd University Hospital, SE- 182 88, Stockholm, Sweden.
  • Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
  • Stockholm Urogynecological Clinic, Stockholm, Sweden.
  • Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet and the Division of Obstetrics and Gynecology at Södersjukhuset, Stockholm, Sweden.
  • Department of Obstetrics and Gynecology, Västerås Central Hospital, Västerås, Sweden.

Förderung

  • Beijing Obstetrics and Gynecology Hospital, Capital Medical University
  • Karolinska Institute

Zitieren

APA

Poutakidis, G., Falconer, C., Altman, D., Johannesson, U., Zhang, A., Ericson, C., Stenberg, M., Altrock, S., & Morcos, E. (2025). Pelvic Organ Prolapse Repair Using Robotic-Assisted Sacral Hysterocolpopexy vs Vaginal Surgery with the Uphold™ System: 1-Year Clinical Outcomes. International Urogynecology Journal. https://doi.org/10.1007/s00192-024-06017-6

Vancouver

Poutakidis G, Falconer C, Altman D, Johannesson U, Zhang A, Ericson C, et al. Pelvic Organ Prolapse Repair Using Robotic-Assisted Sacral Hysterocolpopexy vs Vaginal Surgery with the Uphold™ System: 1-Year Clinical Outcomes. International Urogynecology Journal. 2025. doi:10.1007/s00192-024-06017-6

BibTeX
@article{Poutakidis2025,
  author = {Poutakidis, Georgios and Falconer, Christian and Altman, Daniel and Johannesson, Ulrika and Zhang, Anju and Ericson, Charlotta and Stenberg, Mats and Altrock, Sabine and Morcos, Edward},
  title = {Pelvic Organ Prolapse Repair Using Robotic-Assisted Sacral Hysterocolpopexy vs Vaginal Surgery with the Uphold™ System: 1-Year Clinical Outcomes},
  journal = {International Urogynecology Journal},
  year = {2025},
  doi = {10.1007/s00192-024-06017-6}
}
Kostenlos starten →